$ONFO
Onfolio Holdings, Inc Stock $onfo

$onfo Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000165495423006588 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$1.310M	$1.352M	$385.9K
YoY Change	266.12%	250.26%	-24.99%
Cost Of Revenue	$494.5K	$608.5K	$224.8K
YoY Change	137.6%	170.73%	-1.94%
Gross Profit	$815.6K	$743.2K	$161.2K
YoY Change	444.77%	361.19%	-43.51%
Gross Profit Margin	62.26%	54.98%	41.76%
Selling, General & Admin	$1.573M	$1.696M	$918.1K
YoY Change	15.6%	84.77%	101.12%
% of Gross Profit	192.85%	228.25%	569.71%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$190.1K	$171.0K
YoY Change
% of Gross Profit	23.31%	23.01%
Operating Expenses	$2.124M	$2.094M	$918.1K
YoY Change	56.09%	128.13%	101.12%
Operating Profit	-$1.308M	-$1.351M	-$756.9K
YoY Change	8.03%	78.51%	342.05%
Interest Expense	$8.080K	$64.29K	$8.160K
YoY Change	-7.97%	687.87%	-46.94%
% of Operating Profit
Other Income/Expense, Net	$13.90K	$67.09K	$8.164K
YoY Change	-149.3%	721.79%
Pretax Income	-$1.294M	-$1.284M	-$748.8K
YoY Change	2.34%	71.49%	380.44%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.294M	-$1.284M	-$748.8K
YoY Change	2.34%	71.49%	380.44%
Net Earnings / Revenue	-98.78%	-94.99%	-194.02%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.26	-$0.26	-$53.19K
COMMON SHARES
Basic Shares Outstanding	5.110M shares	5.110M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.052M	$4.664M	$1.231M
YoY Change	854.13%	278.98%
Cash & Equivalents	$4.052M	$4.664M	$1.231M
Short-Term Investments
Other Short-Term Assets	$164.4K	$241.5K	$178.6K
YoY Change	-22.25%	35.23%
Inventory	$118.0K	$90.30K	$97.07K
Prepaid Expenses
Receivables	$106.4K	$115.0K	$29.41K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$4.441M	$5.110M	$1.536M
YoY Change	467.92%	232.79%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$4.244M	$4.220M
YoY Change
Intangibles	$4.185M	$4.556M
YoY Change
Long-Term Investments	$277.2K	$278.8K	$443.0K
YoY Change	-36.89%	-37.06%
Other Assets	$129.5K	$127.8K	$135.1K
YoY Change	-6.67%	-5.39%
Total Long-Term Assets	$8.990M	$9.336M	$1.966M
YoY Change	376.6%	374.78%
TOTAL ASSETS
Total Short-Term Assets	$4.441M	$5.110M	$1.536M
Total Long-Term Assets	$8.990M	$9.336M	$1.966M
Total Assets	$13.43M	$14.45M	$3.502M
YoY Change	403.37%	312.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$352.2K	$342.7K	$261.8K
YoY Change	19.32%	30.89%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$19.22K	$48.63K	$6.660K
YoY Change	-53.53%	630.18%
Long-Term Debt Due	$2.416M	$2.416M	$17.32K
YoY Change	13851.04%	13851.04%
Total Short-Term Liabilities	$3.142M	$3.083M	$570.4K
YoY Change	406.56%	440.53%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.142M	$3.083M	$570.4K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$3.142M	$3.083M	$570.4K
YoY Change	406.56%	440.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$10.26M	-$8.916M
YoY Change
Common Stock	$418.2K	$418.2K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$10.29M	$11.36M	$2.932M
YoY Change
Total Liabilities & Shareholders Equity	$13.43M	$14.45M	$3.502M
YoY Change	403.37%	312.52%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$1.294M	-$1.284M	-$748.8K
YoY Change	2.34%	71.49%	380.44%
Depreciation, Depletion And Amortization	$190.1K	$171.0K
YoY Change
Cash From Operating Activities	-$534.2K	-$1.022M	-$542.5K
YoY Change	-48.17%	88.4%	3146.32%
INVESTING ACTIVITIES
Capital Expenditures			$0.00
YoY Change			-100.0%
Acquisitions		$850.0K	$0.00
YoY Change
Other Investing Activities	$0.00	-$850.0K	-$22.50K
YoY Change	-100.0%	3677.78%	59.46%
Cash From Investing Activities	$0.00	-$850.0K	-$22.50K
YoY Change	-100.0%	3677.78%	-96.85%
FINANCING ACTIVITIES
Cash Dividend Paid		$74.99K	$2.968K
YoY Change		2426.75%
Common Stock Issuance & Retirement, Net			$130.0K
YoY Change			-75.1%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-63.47K	-$135.3K	85.18K
YoY Change	-135.42%	-258.87%	-80.06%
NET CHANGE
Cash From Operating Activities	-534.2K	-$1.022M	-542.5K
Cash From Investing Activities	0.000	-$850.0K	-22.50K
Cash From Financing Activities	-63.47K	-$135.3K	85.18K
Net Change In Cash	-597.7K	-$2.038M	-479.8K
YoY Change	-25.83%	324.69%	58.0%
FREE CASH FLOW
Cash From Operating Activities	-$534.2K	-$1.022M	-$542.5K
Capital Expenditures			$0.00
Free Cash Flow			-$542.5K
YoY Change			-179.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	138028	usd
CY2023Q1	us-gaap	Revenues Revenues	1351734	usd
CY2022Q1	us-gaap	Revenues Revenues	385923	usd
CY2023Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.10	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Beat Percent EffectiveIncomeTaxRateReconciliationBeatPercent	0.50	pure
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2556358	usd
CY2022Q1	us-gaap	Dividends Dividends	43120	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	74994	usd
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	2968	usd
CY2022Q1	onfolio	Revenue In Joint Venture RevenueInJointVenture	30561	usd
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	19241	usd
CY2022Q1	us-gaap	Net Investment Income NetInvestmentIncome	28435	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4852473	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3989450	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4556071	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3864618	usd
CY2021Q1	onfolio	Selling Intellectual Property SellingIntellectualProperty	700000	usd
CY2021Q1	us-gaap	Management Fee Payable ManagementFeePayable	42000	usd
CY2021Q3	onfolio	Selling Intellectual Property SellingIntellectualProperty	84000	usd
CY2022Q2	onfolio	Selling Intellectual Property SellingIntellectualProperty	45694	usd
CY2022Q2	us-gaap	Disposal Group Deferred Gain On Disposal DisposalGroupDeferredGainOnDisposal	34306	usd
CY2023Q1	us-gaap	Related Party Costs RelatedPartyCosts	7392	usd
CY2022Q4	us-gaap	Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome	512000	usd
CY2022Q4	us-gaap	Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome	1443000	usd
CY2022Q4	us-gaap	Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome	692000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	609565	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	756419	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	629571	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	186562	usd
CY2022Q4	onfolio	Unpaid Dividends UnpaidDividends	54404	usd
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	69660	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	onfolio	Description Of Additional Warrants DescriptionOfAdditionalWarrants	On August 29, 2022, the underwriter partially exercised this option and purchased 609,750 additional warrants at the purchase price of $.01 per warrant for aggregate gross proceeds of $6,097.50
CY2023Q1	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	82613	usd
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	5500	usd
CY2023Q1	us-gaap	Public Utilities Interim Rate Increase Decrease Percentage PublicUtilitiesInterimRateIncreaseDecreasePercentage	1.10	pure
CY2023Q1	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	2753750	shares
CY2022Q3	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	13774848	usd
CY2022Q3	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	12225470	usd
CY2020Q4	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	3233336	usd
CY2023Q1	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	191664	usd
CY2023Q1	onfolio	Stock Based Compensation Shares StockBasedCompensationShares	16667	shares
CY2023Q1	onfolio	Share Based Compensation1 ShareBasedCompensation1	10000	usd
CY2023Q1	onfolio	Shares Issued Worth Of Shares Per To Director Value SharesIssuedWorthOfSharesPerToDirectorValue	2500	usd
CY2023Q1	onfolio	Cash Issued To Director CashIssuedToDirector	5000	usd
CY2023Q1	onfolio	Weighted Average Grant Date Fair Value Granted WeightedAverageGrantDateFairValueGranted	0
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	37189	shares
CY2023Q1	onfolio	Weighted Average Grant Date Fair Valueending WeightedAverageGrantDateFairValueending	4.37
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.33
CY2022Q4	us-gaap	Cash Cash	82490	usd
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001825452
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5110195	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5110195	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5110195	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.1	pure
CY2022Q1	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	191664	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.95
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	69660	shares
CY2023Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P8M30D
CY2023Q1	us-gaap	Short Term Debt Interest Rate Increase ShortTermDebtInterestRateIncrease	0.0123	pure
CY2023Q1	us-gaap	Policyholder Dividends Rate On Policy Earnings PolicyholderDividendsRateOnPolicyEarnings	0	pure
CY2023Q1	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	49560	shares
CY2023Q1	us-gaap	Fair Value Option Credit Risk Gains Losses On Assets FairValueOptionCreditRiskGainsLossesOnAssets	363000	usd
CY2023Q1	us-gaap	Option Indexed To Issuers Equity Shares OptionIndexedToIssuersEquityShares	23100	shares
CY2023Q1	us-gaap	Officers Compensation OfficersCompensation	138908	usd
CY2022Q4	onfolio	Due To Related Parties Included In Current Liabilities DueToRelatedPartiesIncludedInCurrentLiabilities	36854	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-41466
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	ONFOLIO HOLDINGS, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	37-1978697
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1007 North Orange Street, 4th Floor
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Wilmington
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	DE
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19801
CY2023Q1	dei	City Area Code CityAreaCode	682
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	990-6920
CY2023Q1	dei	Security12b Title Security12bTitle	Common stock, $0.001 par value
CY2023Q1	dei	Trading Symbol TradingSymbol	ONFO
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5110195	shares
CY2023Q1	us-gaap	Cash Cash	4663522	usd
CY2022Q4	us-gaap	Cash Cash	6701122	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	114962	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	137598	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	90301	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	105129	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	241455	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	212180	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	5110240	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7156029	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4556071	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3864618	usd
CY2023Q1	us-gaap	Goodwill Goodwill	4219501	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4209126	usd
CY2023Q1	us-gaap	Due From Related Parties DueFromRelatedParties	127854	usd
CY2022Q4	us-gaap	Due From Related Parties DueFromRelatedParties	111720	usd
CY2023Q1	onfolio	Total Cost Method Investments TotalCostMethodInvestments	154007	usd
CY2022Q4	onfolio	Total Cost Method Investments TotalCostMethodInvestments	154007	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	278837	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	280326	usd
CY2023Q1	us-gaap	Assets Assets	14446510	usd
CY2022Q4	us-gaap	Assets Assets	15775826	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	342678	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	550454	usd
CY2023Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	30435	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	54404	usd
CY2023Q1	onfolio	Acquisition Notes Payable Current AcquisitionNotesPayableCurrent	2416323	usd
CY2022Q4	onfolio	Acquisition Notes Payable Current AcquisitionNotesPayableCurrent	2456323	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	48627	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	68959	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	60000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	60000	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	185238	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	113251	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3083301	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3303391	usd
CY2023Q1	us-gaap	Liabilities Liabilities	3083301	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3303391	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5110195	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	5110	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	5110	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	20184129	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19950774	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	89490	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	96971	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8915590	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7580490	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	11363209	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	12472435	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14446510	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15775826	usd
CY2023Q1	onfolio	Revenue Services RevenueServices	392401	usd
CY2022Q1	onfolio	Revenue Services RevenueServices	117987	usd
CY2023Q1	onfolio	Revenue Product Sales RevenueProductSales	959333	usd
CY2022Q1	onfolio	Revenue Product Sales RevenueProductSales	267936	usd
CY2023Q1	us-gaap	Revenues Revenues	1351734	usd
CY2022Q1	us-gaap	Revenues Revenues	385923	usd
CY2023Q1	onfolio	Cost Of Revenue Services CostOfRevenueServices	273313	usd
CY2022Q1	onfolio	Cost Of Revenue Services CostOfRevenueServices	128339	usd
CY2023Q1	onfolio	Cost Of Revenue Product Sales CostOfRevenueProductSales	335208	usd
CY2022Q1	onfolio	Cost Of Revenue Product Sales CostOfRevenueProductSales	96431	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	608521	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	224770	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	743213	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	161153	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1696380	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	797490	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	247385	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	43432	usd
CY2023Q1	us-gaap	Acquisition Costs AcquisitionCosts	150614	usd
CY2022Q1	us-gaap	Acquisition Costs AcquisitionCosts	77161	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2094379	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	918083	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1351166	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-756930	usd
CY2023Q1	onfolio	Equity Method Income EquityMethodIncome	6888	usd
CY2022Q1	onfolio	Equity Method Income EquityMethodIncome	10179	usd
CY2023Q1	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	1269	usd
CY2022Q1	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	385	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	56132	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2400	usd
CY2023Q1	us-gaap	Other Income OtherIncome	2802	usd
CY2023Q1	onfolio	Proceeds From Sale Of Series A Preferred Stock ProceedsFromSaleOfSeriesAPreferredStock	0	usd
CY2022Q1	us-gaap	Other Income OtherIncome	0	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	67091	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8164	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1284075	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-748766	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1284075	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-748766	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	51025	usd
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	43120	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1335100	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-791886	usd
CY2023Q1	onfolio	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.26
CY2022Q1	onfolio	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.34
CY2023Q1	onfolio	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	5110196	shares
CY2022Q1	onfolio	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	2354049	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	233355	usd
CY2023Q1	onfolio	Preferred Dividends PreferredDividends	-51025	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-7481	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1284075	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	11363209	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3373805	usd
CY2022Q1	onfolio	Preferred Shares For Cash Amount PreferredSharesForCashAmount	130000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	219660	usd
CY2022Q1	onfolio	Preferred Dividends PreferredDividends	-43120	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-748766	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	2931579	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1284075	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-748766	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	233355	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	219660	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6888	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	10179	usd
CY2023Q1	onfolio	Dividends Received From Equity Method Investment DividendsReceivedFromEquityMethodInvestment	-8377	usd
CY2022Q1	onfolio	Dividends Received From Equity Method Investment DividendsReceivedFromEquityMethodInvestment	-7426	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	170996	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-22636	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	14782	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-14828	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1328	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	29275	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	18767	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-207776	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	39262	usd
CY2023Q1	onfolio	Increase Decrease In Due To Joint Ventures IncreaseDecreaseInDueToJointVentures	-16134	usd
CY2022Q1	onfolio	Increase Decrease In Due To Joint Ventures IncreaseDecreaseInDueToJointVentures	-33142	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	71987	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	15980	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	0	usd
CY2022Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-480	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1021969	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-542460	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	850000	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	0	usd
CY2022Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	22500	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-850000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-22500	usd
CY2022Q1	onfolio	Proceeds From Sale Of Series A Preferred Stock ProceedsFromSaleOfSeriesAPreferredStock	130000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	74994	usd
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	2968	usd
CY2023Q1	onfolio	Payment Of Contribution To Joint Venture Note Payable PaymentOfContributionToJointVentureNotePayable	0	usd
CY2022Q1	onfolio	Payment Of Contribution To Joint Venture Note Payable PaymentOfContributionToJointVentureNotePayable	20000	usd
CY2023Q1	onfolio	Payments On Acquisition Note Payable PaymentsOnAcquisitionNotePayable	40000	usd
CY2022Q1	onfolio	Payments On Acquisition Note Payable PaymentsOnAcquisitionNotePayable	0	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	20332	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	21855	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-135326	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	85177	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-30305	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2037600	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-479783	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6701122	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1710318	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4663522	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1230535	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	18836	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	2400	usd
CY2022Q3	onfolio	Description Of Dominic Wells DescriptionOfDominicWells	the Company issued 2,000,000 shares to Dominic Wells, the Company’s CEO in exchange for 100% of the membership interest of Onfolio LLC
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	266601	usd
CY2023Q1	us-gaap	Variable Interest Entity Ownership Percentage VariableInterestEntityOwnershipPercentage	0.50	pure
CY2023Q1	us-gaap	Investment Company Total Return Payment To Fund By Affiliate InvestmentCompanyTotalReturnPaymentToFundByAffiliate	0.358	pure
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the balance sheet. The Company uses significant judgements when making estimates related to the assessment of control over variable interest entities, valuation of deferred tax assets and impairment of long lived assets. Actual results could differ from those estimates.</p>
CY2023Q1	onfolio	Deferred Revenues DeferredRevenues	185238	usd
CY2023Q1	us-gaap	Management Fee Expense ManagementFeeExpense	40612	usd
CY2022Q1	us-gaap	Management Fee Expense ManagementFeeExpense	66102	usd
CY2022Q1	us-gaap	Advertising Expense AdvertisingExpense	51886	usd
CY2023Q1	us-gaap	Production Costs ProductionCosts	126711	usd
CY2022Q1	us-gaap	Production Costs ProductionCosts	129908	usd
CY2023Q1	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	917810	usd
CY2023Q1	onfolio	Cost Of Revenue Policytextblock CostOfRevenuePolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cost of product revenue consists primarily of costs associated with the acquisition and shipment of products being sold through the Company’s online marketplaces, and the costs of its service revenue, which include website content creation costs including contract labor, service fulfillment, domain and hosting costs and certain software costs related to website operations.</p>
CY2023Q1	onfolio	Expected Dividendspolicytextblock ExpectedDividendspolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Expected Dividends. - </span>We have never declared or paid any cash dividends on our common stock and do not expect to do so in the foreseeable future. Accordingly, we use an expected dividend yield of zero to calculate the grant-date fair value of a stock option.</p>
CY2023Q1	onfolio	Expected Volatilitypolicytextblock ExpectedVolatilitypolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Expected Volatility. - </span>The expected volatility is a measure of the amount by which our stock price is expected to fluctuate during the expected term of options granted. We determine the expected volatility solely based upon the historical volatility of a peer group of companies of similar size and with similar operations.</p>
CY2023Q1	onfolio	Risk Free Interest Ratepolicytextblock RiskFreeInterestRatepolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Risk-Free Interest Rate. </span> - The risk-free interest rate is the implied yield available on U.S. Treasury <em>zero</em>-coupon issues with a remaining term equal to the option’s expected term on the grant date.</p>
CY2023Q1	onfolio	Expected Termpolicytextblock ExpectedTermpolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Expected Term. </span>The expected life of stock options granted is based on the actual vesting date and the end of the contractual term.</p>
CY2023Q1	onfolio	Stock Option Exercise Price And Grant Date Price Of Common Stockpolicytextblock StockOptionExercisePriceAndGrantDatePriceOfCommonStockpolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Stock Option Exercise Price and Grant Date Price of Common Stock. -</span> Currently the Company utilizes the most recent cash sale closing price of its common stock as the most reasonable indication of fair value.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company accounts for compensation cost for stock option plans and for share based payments to non-employees in accordance with ASC 505, “Accounting for Equity Instruments Issued to Non-Employees for Acquiring, or in Conjunction with Selling, Goods or Services“. Share-based awards to non-employees are expensed over the period in which the related services are rendered at their fair value.</p>
CY2023Q1	onfolio	Revenue In Joint Venture RevenueInJointVenture	22210	usd
CY2023Q1	us-gaap	Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome	85000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P4Y
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	742728	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	332966	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	12860	shares
CY2022	onfolio	Proceeds From Customers1 ProceedsFromCustomers1	321500	usd
CY2021	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	56600	shares
CY2021	onfolio	Proceeds From Customers1 ProceedsFromCustomers1	1415000	usd
CY2023Q1	us-gaap	Dividends Dividends	51025	usd
CY2023Q1	onfolio	Unpaid Dividends UnpaidDividends	30435	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	2753750	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	413063	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	826126	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	0.15	pure
CY2023Q1	onfolio	Shares Awarded To The Company Board Of Directors SharesAwardedToTheCompanyBoardOfDirectors	2800	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	59850	shares
CY2022Q4	onfolio	Weighted Average Grant Date Fair Valueending WeightedAverageGrantDateFairValueending	4.15
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.11
CY2023Q1	onfolio	Weighted Average Grant Date Fair Value Exercised WeightedAverageGrantDateFairValueExercised	0
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	22661	shares
CY2023Q1	onfolio	Weighted Average Grant Date Fair Value Forfeited And Cancelled WeightedAverageGrantDateFairValueForfeitedAndCancelled	-3.69
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	13.68
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	23406	shares
CY2023Q1	onfolio	Weighted Average Grant Date Fair Valueexercisable WeightedAverageGrantDateFairValueexercisable	4.37
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.27
CY2023Q1	us-gaap	Net Amount At Risk By Product And Guarantee Weighted Average Period Remaining1 NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1	P4Y4M24D
CY2023Q1	onfolio	Due From Related Parties Included In Non Current Assets DueFromRelatedPartiesIncludedInNonCurrentAssets	91000	usd
CY2022Q4	onfolio	Due From Related Parties Included In Non Current Assets DueFromRelatedPartiesIncludedInNonCurrentAssets	74866	usd
CY2023Q1	onfolio	Due To Related Parties Included In Current Liabilities DueToRelatedPartiesIncludedInCurrentLiabilities	36854	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	73000	usd
CY2022Q4	us-gaap	Public Utilities Approved Rate Increase Decrease Percentage PublicUtilitiesApprovedRateIncreaseDecreasePercentage	0.17	pure
CY2023Q1	onfolio	Company Owed CompanyOwed	48627	usd
CY2022Q4	onfolio	Company Owed CompanyOwed	68959	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
onfolio-20230331_def.xml	Edgar Link	unprocessable
onfolio-20230331_cal.xml	Edgar Link	unprocessable
0001654954-23-006588-index-headers.html	Edgar Link	pending
0001654954-23-006588-index.html	Edgar Link	pending
0001654954-23-006588.txt	Edgar Link	pending
0001654954-23-006588-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
onfolio-20230331.xsd	Edgar Link	pending
onfolio_10q.htm	Edgar Link	pending
onfolio_ex311.htm	Edgar Link	pending
onfolio_ex312.htm	Edgar Link	pending
onfolio_ex321.htm	Edgar Link	pending
onfolio_ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
onfolio-20230331_lab.xml	Edgar Link	unprocessable
onfolio-20230331_pre.xml	Edgar Link	unprocessable
onfolio_10q_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ONFO
Onfolio Holdings, Inc Stock $onfo

2023 Q2 Form 10-Q Financial Statement

#000165495423006588 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONFO Onfolio Holdings, Inc Stock $onfo

2023 Q2 Form 10-Q Financial Statement

#000165495423006588 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONFO
Onfolio Holdings, Inc Stock $onfo